Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9422166 | 0.80 | ALOX15 (0.37) | — | |
| SCHEMBL17974552 | 0.79 | ALDH1A1 (0.33) | ALDH1A1 | |
| SCHEMBL27484483 | 0.71 | ALOX15 (0.33) | ALDH1A1 | |
| SCHEMBL11230563 | 0.70 | ALDH1A1 (0.35) | ALDH1A1 | |
| SCHEMBL7942993 | 0.70 | ALDH1A1 (0.42) | ALDH1A1TSHR | |
| SCHEMBL3281463 | 0.68 | ALDH1A1 (0.41) | ALDH1A1TSHR | |
| SCHEMBL18068501 | 0.68 | ALDH1A1 (0.31) | ALDH1A1 | |
| SCHEMBL25477401 | 0.68 | NAAA (0.36) | ALDH1A1TSHR | |
| SCHEMBL6800120 | 0.68 | ALDH1A1 (0.46) | ALDH1A1TSHR | |
| SCHEMBL6048958 | 0.68 | ALDH1A1 (0.42) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2298820-B1 | POROUS RESIN BEAD AND METHOD FOR PRODUCING NUCLEIC ACID USING THE SAME | NITTO DENKO CORP (JP) | 2020-11-04 | — | — | EP | disclosed |
| EP-2298821-B1 | POROUS RESIN BEAD AND METHOD FOR PRODUCING NUCLEIC ACID USING THE SAME | NITTO DENKO CORP (JP) | 2020-07-29 | — | — | EP | disclosed |
| EP-2886564-B1 | Porous resin bead and production method of nucleic acid by using same | NITTO DENKO CORP (JP) | 2016-09-21 | — | — | EP | disclosed |
| EP-2886564-A1 | Porous resin bead and production method of nucleic acid by using same | Nitto Denko Corporation (JP) | 2015-06-24 | — | — | EP | disclosed |
| US-20150152234-A1 | POROUS RESIN BEAD AND PRODUCTION METHOD OF NUCLEIC ACID BY USING SAME | NITTO DENKO CORPORATION (JP) | 2015-06-04 | — | — | US | disclosed |
| US-8802745-B2 | Porous resin bead and method for producing nucleic acid using the same | NITTO DENKO CORPORATION (JP) | 2014-08-12 | — | — | US | disclosed |
| US-8653152-B2 | Porous resin bead and method for producing nucleic acid using the same | NITTO DENKO CORPORATION (JP) | 2014-02-18 | — | — | US | disclosed |
| EP-2298821-A1 | Porous Resin Bead and Method for Producing Nucleic Acid Using the Same | Nitto Denko Corporation (JP) | 2011-03-23 | — | — | EP | disclosed |
| EP-2298820-A1 | Porous Resin Bead and Method for Producing Nucleic Acid Using the Same | Nitto Denko Corporation (JP) | 2011-03-23 | — | — | EP | disclosed |
| US-20110065822-A1 | POROUS RESIN BEAD AND METHOD FOR PRODUCING NUCLEIC ACID USING THE SAME | NITTO DENKO CORPORATION (JP) | 2011-03-17 | — | — | US | disclosed |
| US-20110065818-A1 | POROUS RESIN BEAD AND METHOD FOR PRODUCING NUCLEIC ACID USING THE SAME | NITTO DENKO CORPORATION (JP) | 2011-03-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110065822-A1 | POROUS RESIN BEAD AND METHOD FOR PRODUCING NUCLEIC ACID USING THE SAME | PCNA, PARN, PHAX | ALDH1A1 3496/4885TSHR 3962/4885 |
| US-20110065818-A1 | POROUS RESIN BEAD AND METHOD FOR PRODUCING NUCLEIC ACID USING THE SAME | PCNA, ARID2, PARN | ALDH1A1 3309/4885TSHR 3703/4885 |
| US-20150152234-A1 | POROUS RESIN BEAD AND PRODUCTION METHOD OF NUCLEIC ACID BY USING SAME | PCNA, ELL, NUP205 | ALDH1A1 3586/4885TSHR 4462/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.